WuXi AppTec nets $950m from H-share tap

Pharma_drugs_adobe_575x375.jpg
By Jonathan Breen
29 Jul 2020

Chinese pharmaceutical company WuXi AppTec has raised HK$7.37bn ($950.4m) of fresh equity, in a hotly-anticipated tap of a new mandate to issue A-shares and H-shares.

WuXi first announced plans to issue new stock in Hong Kong and on the Mainland in March this year, aiming to raise up to Rmb6.5bn ($928.1m) from an A-share placement and an unspecified amount from a sale of H-shares.

The firm was eyeing capital to help fund ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial